Israel Englander Dr Reddys Laboratories LTD Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

A detailed history of Israel Englander (Millennium Management LLC) transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Millennium Management LLC holds 159,739 shares of RDY stock, worth $2.35 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

159,739

Previous 332,502 51.96%

Holding current value

$2.35 Million

Previous $25.3 Million 49.9%

% of portfolio

0.01%

Previous 0.01%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$75.41 - $84.21 $13 Million - $14.5 Million	-172,763 Reduced 51.96%	159,739 $12.7 Million
Q2 2024 Aug 14, 2024	BUY	$68.26 - $76.19 $8.63 Million - $9.64 Million	126,472 Added 61.39%	332,502 $25.3 Million
Q1 2024 May 15, 2024	BUY	$67.36 - $77.59 $12.6 Million - $14.5 Million	186,471 Added 953.38%	206,030 $15.1 Million
Q4 2023 Feb 14, 2024	SELL	$64.27 - $69.9 $19.8 Million - $21.6 Million	-308,379 Reduced 94.04%	19,559 $1.36 Million
Q2 2023 Aug 14, 2023	BUY	$53.34 - $63.11 $11.1 Million - $13.1 Million	207,955 Added 173.32%	327,938 $20.7 Million
Q1 2023 May 15, 2023	BUY	$51.63 - $56.93 $5.09 Million - $5.61 Million	98,624 Added 461.74%	119,983 $6.83 Million
Q4 2022 Feb 14, 2023	BUY	$51.15 - $57.45 $305,007 - $342,574	5,963 Added 38.73%	21,359 $1.11 Million
Q3 2022 Nov 14, 2022	SELL	$49.9 - $57.32 $1.89 Million - $2.17 Million	-37,848 Reduced 71.08%	15,396 $806,000
Q2 2022 Aug 15, 2022	SELL	$49.62 - $58.13 $30.1 Million - $35.3 Million	-607,150 Reduced 91.94%	53,244 $2.95 Million
Q1 2022 May 16, 2022	BUY	$48.27 - $65.25 $19.5 Million - $26.4 Million	404,639 Added 158.21%	660,394 $36.8 Million
Q4 2021 Feb 14, 2022	BUY	$59.5 - $67.25 $3.01 Million - $3.4 Million	50,594 Added 24.66%	255,755 $16.7 Million
Q3 2021 Nov 15, 2021	BUY	$60.19 - $75.29 $9.34 Million - $11.7 Million	155,138 Added 310.13%	205,161 $13.4 Million
Q2 2021 Aug 16, 2021	SELL	$62.12 - $74.2 $16.7 Million - $19.9 Million	-268,844 Reduced 84.31%	50,023 $3.68 Million
Q1 2021 May 17, 2021	BUY	$57.98 - $73.08 $2.28 Million - $2.88 Million	39,362 Added 14.08%	318,867 $19.6 Million
Q4 2020 Feb 16, 2021	BUY	$62.61 - $71.29 $17 Million - $19.4 Million	271,572 Added 3423.32%	279,505 $19.9 Million
Q3 2020 Nov 16, 2020	BUY	$51.39 - $72.41 $407,676 - $574,428	7,933 New	7,933 $552,000
Q2 2020 Aug 14, 2020	SELL	$39.55 - $54.65 $368,289 - $508,900	-9,312 Closed	0 $0
Q1 2020 May 14, 2020	SELL	$34.75 - $45.85 $1.98 Million - $2.61 Million	-57,024 Reduced 85.96%	9,312 $376,000
Q4 2019 Feb 14, 2020	BUY	$36.66 - $41.78 $265,638 - $302,737	7,246 Added 12.26%	66,336 $2.69 Million
Q3 2019 Nov 14, 2019	BUY	$34.82 - $39.26 $2.06 Million - $2.32 Million	59,090 New	59,090 $2.24 Million
Q2 2019 Aug 14, 2019	SELL	$36.05 - $42.76 $1.13 Million - $1.34 Million	-31,282 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$35.77 - $40.57 $1.12 Million - $1.27 Million	31,282 New	31,282 $1.27 Million
Q4 2018 Feb 14, 2019	SELL	$31.89 - $38.44 $5.94 Million - $7.16 Million	-186,224 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$29.25 - $36.73 $3.47 Million - $4.36 Million	-118,653 Reduced 38.92%	186,224 $6.44 Million
Q2 2018 Aug 14, 2018	BUY	$28.49 - $35.06 $8.26 Million - $10.2 Million	289,942 Added 1941.36%	304,877 $9.82 Million
Q1 2018 May 15, 2018	SELL	$31.93 - $39.54 $285,933 - $354,080	-8,955 Reduced 37.48%	14,935 $488,000
Q4 2017 Feb 14, 2018	BUY	$34.15 - $37.62 $606,606 - $668,244	17,763 Added 289.91%	23,890 $897,000
Q3 2017 Nov 14, 2017	BUY	$30.11 - $37.72 $184,483 - $231,110	6,127	6,127 $219,000

Others Institutions Holding RDY

# of Institutions

245

Shares Held

23.1M

Call Options Held

12.7K

Put Options Held

6.1K

View Full List

About DR REDDYS LABORATORIES LTD

Ticker RDY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 166,028,992
Market Cap $2.44B
Description
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...

More about RDY

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account